Blood-based proteomic biomarkers of Alzheimer’s disease pathology
The complexity of Alzheimer’s disease (AD) and its long prodromal phase poses challenges for early diagnosis and yet allows for the possibility of the development of disease modifying treatments for secondary prevention. It is, therefore, of importance to develop biomarkers, in particular, in the pr...
| Päätekijät: | , , |
|---|---|
| Aineistotyyppi: | Journal article |
| Julkaistu: |
Frontiers
2015
|